BRAIN Act of 2021

H.R. 1, the One Big Beautiful Bill Act Issues related to health care workforce shortages Issues related to funding for the Early Hearing Detection and Intervention Act (Public Law 117-241) Stop CMV Act (H.R. 5435/S. 2842) Bipartisan Premium Tax Credit Extension Act (H.R. 5145) Various issues related to implementation of the ACA, including Essential Health Benefits and marketplace plans Various issues related to non-discrimination legislation and regulation Issues related to coverage of gender-affirming care/gender-affirming voice therapy Issues related to health information technology, including interoperability Issues related to funding in Fiscal Year 2025 for programs administered by the Department of Health and Human Services and National Institutes of Health H.R. 2332/S. 1101, States Handling Access to Reciprocity for Employment Act Issues related to coverage of and support for individuals who stutter through federal health programs Issues related to consolidation in the health care industry. Workplace Violence Prevention for Health Care and Social Service Workers Act (H.R. 2531/S. 1232) Allys Act (H.R. 4606)

Client expense: $290,000 · Firm income: Not reported

Government targets: Administration on Aging, Centers For Disease Control & Prevention (CDC), Consumer Product Safety Commission (CPSC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE

Gun violence issues and higher education H.R.698/S.25, Assault Weapons Ban H.R.660/S.173, Ethan's Law H.R.4184/S.2048, Equal Access to Justice for Victims of Gun Violence Act S.494, Background Check Expansion Act H.R.715, Bipartisan Background Checks Act of 2023 H.R.2403, Enhanced Background Checks Act of 2023 H.R.5003/S.2638, Break the Cycle of Violence Act H.R.2390/S.1026, Gun Violence Prevention Research Act Monitor Gun Violence Prevention related issues, as follows: Increased funding for the STOP School Violence Act H.Res.1404, Resolution on Keeping guns out of the classroom Funding to support STOP School Violence Act grants Supporting community violence intervention funding in FY 25 S.3369, GOSAFE Act S.2926, Stop Arming Cartels Act H.R.8271, ATF DATA Act Safe storage, community violence intervention programs, school resource officers H.R.4184/S.2048, the Equal Access to Justice for Victims of Gun Violence Act S.3677, the Undetectable Firearms Act Reinstatement of assault weapons ban S. 3223, the Ammunition Modernization and Monitoring Oversight Act H.R.698/S.25, Assault Weapons Ban of 2023 H.R.660/S.173 and H.R.660, Ethan's Law H.R.4184/S.2048, Equal Access to Justice for Victims of Gun Violence Act S.494, Background Check Expansion Act H.R.715, Bipartisan Background Checks Act of 2023 H.R.2403, Enhanced Background Checks Act of 2023 H.R.5003/S.2638, Break the Cycle of Violence Act H.R.2390/S.1026, Gun Violence Prevention Research Act of 2023 H.R.6754, School Violence Prevention Act Funding for gun violence prevention research New White House Office of Gun Violence Prevention H.R.5435/S.2776, Disarm Hate Act, Entirety H.J.Res.44, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Alcohol, Tobacco, Firearms, and Explosives relating to "Factoring Criteria for Firearms with Attached 'Stabilizing Braces'", Entirety School Safety and gun control related issues and initiatives Public Law 117-159, the Bipartisan Safer Communities Act Gun violence prevention H.R.698/S.25, Assault Weapons Ban of 2023, Gun Safety related issues S.14, the Age 21 Act Protecting Our Kids Act H.R.768/S.247, Extreme Risk Protection Order Expansion Act of 2023 Raise the Age Act Community violence intervention, Firearm school safety appropriations funding H.R.715/S.494, Background Checks Act H.R.2403, Enhanced Background Checks Act of 2021 H.R.660/S.173, Ethans Law H.R.1005/S.411, EAGLES Act School Safety and gun control related issues and initiatives Gun Violence Trauma related issues Assault Weapons related issues and initiatives Safe Firearm Storage related issues S.1083, Securing Our Schools Act S.1082, Protect Our children's Schools Act Bureau of Alcohol, Tobacco, Firearms and Explosives proposed regulation on Definition of Engaged in the Business as a Dealer in Firearms Docket #ATF 2022R-17

H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act  S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care

Client expense: $200,000 · Firm income: Not reported

H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act  S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care

Client expense: $160,000 · Firm income: Not reported

Increased funding for the STOP School Violence Act H.Res.1404, Resolution on Keeping guns out of the classroom Monitor Gun Violence Prevention related issues, as follows: H.R.8669, the Safe Workplaces Act Funding to support STOP School Violence Act grants Supporting community violence intervention funding in FY 25 Supporting community violence intervention funding in FY 25 from healthcare perspective Oversight of the Bureau of Alcohol, Tobacco, Firearms, and Explosives Section 413 of the Fiscal Year 2025 Military Construction, Veterans Affairs, and Related Agencies appropriations legislation S.3369, GOSAFE Act S.2926, Stop Arming Cartels Act H.R.8271, ATF DATA Act Safe storage, community violence intervention programs, school resource officers H.R.4184/S.2048, the Equal Access to Justice for Victims of Gun Violence Act S.3677, the Undetectable Firearms Act Reinstatement of assault weapons ban S. 3223, the Ammunition Modernization and Monitoring Oversight Act H.R.698/S.25, Assault Weapons Ban of 2023 H.R.660/S.173 and H.R.660, Ethan's Law H.R.4184/S.2048, Equal Access to Justice for Victims of Gun Violence Act S.494, Background Check Expansion Act H.R.715, Bipartisan Background Checks Act of 2023 H.R.2403, Enhanced Background Checks Act of 2023 H.R.5003/S.2638, Break the Cycle of Violence Act H.R.2390/S.1026, Gun Violence Prevention Research Act of 2023 H.R.6754, School Violence Prevention Act Assault Weapons Ban Funding for gun violence prevention research New White House Office of Gun Violence Prevention H.R.5435/S.2776, Disarm Hate Act, Entirety H.J.Res.44, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Alcohol, Tobacco, Firearms, and Explosives relating to "Factoring Criteria for Firearms with Attached 'Stabilizing Braces'", Entirety School Safety and gun control related issues and initiatives Public Law 117-159, the Bipartisan Safer Communities Act Gun violence prevention H.R.698/S.25, Assault Weapons Ban of 2023, Gun Safety related issues S.14, the Age 21 Act Protecting Our Kids Act H.R.768/S.247, Extreme Risk Protection Order Expansion Act of 2023 Raise the Age Act Community violence intervention, Firearm school safety appropriations funding H.R.715/S.494, Background Checks Act H.R.2403, Enhanced Background Checks Act of 2021 H.R.660/S.173, Ethans Law H.R.1005/S.411, EAGLES Act School Safety and gun control related issues and initiatives Gun Violence Trauma related issues Assault Weapons related issues and initiatives Safe Firearm Storage related issues S.1083, Securing Our Schools Act S.1082, Protect Our children's Schools Act Bureau of Alcohol, Tobacco, Firearms and Explosives proposed regulation on Definition of Engaged in the Business as a Dealer in Firearms Docket #ATF 2022R-17

H.R.8669, the Safe Workplaces Act Monitor Gun Violence Prevention related issues, as follows: Funding to support STOP School Violence Act grants Supporting community violence intervention funding in FY 25 Supporting community violence intervention funding in FY 25 from healthcare perspective Denounce violence and white supremacist conspiracy theories Oversight of the Bureau of Alcohol, Tobacco, Firearms, and Explosives Section 413 of the Fiscal Year 2025 Military Construction, Veterans Affairs, and Related Agencies appropriations legislation S.3369, GOSAFE Act S.2926, Stop Arming Cartels Act H.R.8271, ATF DATA Act Hearing on Gun Trafficking and Mexico Safe storage, community violence intervention programs, school resource officers H.R.4184/S.2048, the Equal Access to Justice for Victims of Gun Violence Act S.3677, the Undetectable Firearms Act Reinstatement of assault weapons ban S. 3223, the Ammunition Modernization and Monitoring Oversight Act H.R.698/S.25, Assault Weapons Ban of 2023 H.R.660/S.173 and H.R.660, Ethan's Law H.R.4184/S.2048, Equal Access to Justice for Victims of Gun Violence Act S.494, Background Check Expansion Act H.R.715, Bipartisan Background Checks Act of 2023 H.R.2403, Enhanced Background Checks Act of 2023 H.R.5003/S.2638, Break the Cycle of Violence Act H.R.2390/S.1026, Gun Violence Prevention Research Act of 2023 H.R.6754, School Violence Prevention Act Assault Weapons Ban Funding for gun violence prevention research New White House Office of Gun Violence Prevention H.R.5435/S.2776, Disarm Hate Act, Entirety H.J.Res.44, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Alcohol, Tobacco, Firearms, and Explosives relating to "Factoring Criteria for Firearms with Attached 'Stabilizing Braces'", Entirety School Safety and gun control related issues and initiatives Public Law 117-159, the Bipartisan Safer Communities Act Gun violence prevention H.R.698/S.25, Assault Weapons Ban of 2023, Gun Safety related issues S.14, the Age 21 Act Protecting Our Kids Act H.R.768/S.247, Extreme Risk Protection Order Expansion Act of 2023 Raise the Age Act Community violence intervention, Firearm school safety appropriations funding H.R.715/S.494, Background Checks Act H.R.2403, Enhanced Background Checks Act of 2021 H.R.660/S.173, Ethans Law H.R.1005/S.411, EAGLES Act School Safety and gun control related issues and initiatives Gun Violence Trauma related issues Assault Weapons related issues and initiatives Safe Firearm Storage related issues S.1083, Securing Our Schools Act S.1082, Protect Our children's Schools Act Bureau of Alcohol, Tobacco, Firearms and Explosives proposed regulation on Definition of Engaged in the Business as a Dealer in Firearms Docket #ATF 2022R-17

H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act  S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care

Client expense: $450,000 · Firm income: Not reported

H.R. 2389: Resident Physician Shortage Reduction Act S. 665 / H.R. 4942: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act  S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective Related issues impacting access to neurologic care

Client expense: $540,000 · Firm income: Not reported

S.3369, GOSAFE Act S.2926, Stop Arming Cartels Act H.R.8271, ATF DATA Act Hearing on Gun Trafficking and Mexico Safe storage, community violence intervention programs, school resource officers Gun violence prevention and AFT Paraprofessionals & school-related personnel. Monitor Gun Violence Prevention related issues, as follows: H.R.4184/S.2048, the Equal Access to Justice for Victims of Gun Violence Act S.3677, the Undetectable Firearms Act Reinstatement of assault weapons ban S. 3223, the Ammunition Modernization and Monitoring Oversight Act H.R.698/S.25, Assault Weapons Ban of 2023 H.R.660/S.173 and H.R.660, Ethan's Law H.R.4184/S.2048, Equal Access to Justice for Victims of Gun Violence Act S.494, Background Check Expansion Act H.R.715, Bipartisan Background Checks Act of 2023 H.R.2403, Enhanced Background Checks Act of 2023 H.R.5003/S.2638, Break the Cycle of Violence Act H.R.2390/S.1026, Gun Violence Prevention Research Act of 2023 H.R.6754, School Violence Prevention Act Assault Weapons Ban Funding for gun violence prevention research New White House Office of Gun Violence Prevention H.R.5435/S.2776, Disarm Hate Act, Entirety H.J.Res.44, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Alcohol, Tobacco, Firearms, and Explosives relating to "Factoring Criteria for Firearms with Attached 'Stabilizing Braces'", Entirety School Safety and gun control related issues and initiatives Public Law 117-159, the Bipartisan Safer Communities Act Gun violence prevention H.R.698/S.25, Assault Weapons Ban of 2023, Gun Safety related issues S.14, the Age 21 Act Protecting Our Kids Act H.R.768/S.247, Extreme Risk Protection Order Expansion Act of 2023 Raise the Age Act Community violence intervention, Firearm school safety appropriations funding H.R.715/S.494, Background Checks Act H.R.2403, Enhanced Background Checks Act of 2021 H.R.660/S.173, Ethans Law H.R.1005/S.411, EAGLES Act School Safety and gun control related issues and initiatives Gun Violence Trauma related issues Assault Weapons related issues and initiatives Safe Firearm Storage related issues S.1083, Securing Our Schools Act S.1082, Protect Our children's Schools Act Bureau of Alcohol, Tobacco, Firearms and Explosives proposed regulation on Definition of Engaged in the Business as a Dealer in Firearms Docket #ATF 2022R-17

Reinstatement of assault weapons ban S. 3223, the Ammunition Modernization and Monitoring Oversight Act Gun Violence Prevention related issues, as follows: H.R.698/S.25, Assault Weapons Ban of 2023 H.R.660/S.173 and H.R.660, Ethan's Law H.R.4184/S.2048, Equal Access to Justice for Victims of Gun Violence Act S.494, Background Check Expansion Act H.R.715, Bipartisan Background Checks Act of 2023 H.R.2403, Enhanced Background Checks Act of 2023 H.R.5003/S.2638, Break the Cycle of Violence Act H.R.2390/S.1026, Gun Violence Prevention Research Act of 2023 Monitor the following: S.3369, GOSAFE Act H.R.6754, School Violence Prevention Act Assault Weapons Ban Funding for gun violence prevention research New White House Office of Gun Violence Prevention H.R.5435/S.2776, Disarm Hate Act, Entirety Bureau of Alcohol, Tobacco, Firearms and Explosives proposed rule (Docket No ATF 2022R-17) H.J.Res.44, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Alcohol, Tobacco, Firearms, and Explosives relating to "Factoring Criteria for Firearms with Attached 'Stabilizing Braces'", Entirety School Safety and gun control related issues and initiatives Public Law 117-159, the Bipartisan Safer Communities Act Gun violence prevention H.R.698/S.25, Assault Weapons Ban of 2023, Gun Safety related issues S.14, the Age 21 Act Protecting Our Kids Act H.R.768/S.247, Extreme Risk Protection Order Expansion Act of 2023 Raise the Age Act Help Education After Loss (HEAL) Act School Shooting Safety and Preparedness Act Community violence intervention funding H.R.715/S.494, Background Checks Act H.R.2403, Enhanced Background Checks Act of 2021 School Safety Drill Research Act H.R.660/S.173, Ethans Law H.R.1005/S.411, EAGLES Act School Safety and gun control related issues and initiatives Gun Violence Trauma related issues Assault Weapons related issues and initiatives Safe Firearm Storage related issues S.1083, Securing Our Schools Act S.1082, Protect Our children's Schools Act Bureau of Alcohol, Tobacco, Firearms and Explosives proposed regulation on Definition of Engaged in the Business as a Dealer in Firearms Docket #ATF 2022R-17

H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act  S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective

Client expense: $180,000 · Firm income: Not reported

Monitor the following: Assault Weapons Ban Funding for gun violence prevention research New White House Office of Gun Violence Prevention H.R.5435/S.2776, Disarm Hate Act, Entirety Bureau of Alcohol, Tobacco, Firearms and Explosives proposed rule (Docket No ATF 2022R-17) H.J.Res.44, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Alcohol, Tobacco, Firearms, and Explosives relating to "Factoring Criteria for Firearms with Attached 'Stabilizing Braces'", Entirety School Safety and gun control related issues and initiatives Public Law 117-159, the Bipartisan Safer Communities Act Gun violence prevention H.R.698/S.25, Assault Weapons Ban of 2023, Gun Safety related issues S.14, the Age 21 Act Protecting Our Kids Act H.R.768/S.247, Extreme Risk Protection Order Expansion Act of 2023 Raise the Age Act Help Education After Loss (HEAL) Act School Shooting Safety and Preparedness Act Community violence intervention funding H.R.715/S.494, Background Checks Act H.R.2403, Enhanced Background Checks Act of 2021 School Safety Drill Research Act H.R.660/S.173, Ethans Law H.R.1005/S.411, EAGLES Act School Safety and gun control related issues and initiatives Gun Violence Trauma related issues Assault Weapons related issues and initiatives Safe Firearm Storage related issues S.1083, Securing Our Schools Act S.1082, Protect Our children's Schools Act

Client expense: $250,000 · Firm income: Not reported

H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act  S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective

Client expense: $160,000 · Firm income: Not reported

H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act  S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID Improvements in the National Coverage Determination (NCD) process related to treatment for Alzheimer's disease Support for access to innovative treatments in the field of neurology that are both safe and effective

Client expense: $380,000 · Firm income: Not reported

H.R. 2389: Resident Physician Shortage Reduction Act S. 665: Conrad State 30 and Physician Access Reauthorization Act S. 704 / H.R. 1202: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act  S. 652 / H.R. 2630 Safe Step Act Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program Support for research related to Long COVID

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)

Client expense: $42,877 · Firm income: Not reported

H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)

Client expense: $58,169 · Firm income: Not reported

H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)

S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.

Client expense: $140,000 · Firm income: Not reported

H.R. 2815, BIOSIM Act, support passage H.R. 2855, the STAR Rating for Biosimilars Act, support passage H.R. 2846- Ensuring Access to Lower-Cost Medicines for Seniors Act of 021 - support passage S.2210/H.R. 4131- Better Care Better Jobs Act - support passage S.2315- Medicaid Saves Lives Act, support passage S.2327- Seniors Prescription Drug Relief Act- support passage S.2562-Choose Home Care Act of 2021- support passage S.2612- Prevent Interruptions in Physical Therapy Act of 2021- support passage S. 2694- Nursing Home Improvement and Accountability Act of 2021 - support passage H.R. 5011- Choose Medicare Act, support passage H.R. 5099- Lowering Medicare Premiums and Prescription Drug Costs Act, support passage H.R. 5165 - Improving Medicare Coverage Act - support passage H.R. 5237 - "To amend titles XI, XVIII, and XIX of the Social Security Act to lower prescription drug prices in the Medicare and Medicaid programs, to improve transparency related to pharmaceutical prices and transactions, to lower patients' out-of-pocket costs, and to ensure accountability to taxpayers, and for other purposes." - monitor for position determination H.R. 5260 - Reduced Costs and Continued Cures Act - monitor for position determination H.R. 5536 - SMART Act - support passage H.R. 5514 Choose Home Care Act of 2021, support passage Senate Reconciliation/Senate Finance prescription drug pricing package - supporting provisions that allow Medicare to negotiate for a specific amount of drugs, implement a $2,000 out-of-pocket cap on drug costs in Medicare Part D and a smoothing mechanism so that people in Medicare can spread their costs over the course of the year, and limit drug price increases by implementing rebates if prescription drug prices rise faster than inflation. H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)

H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)

Client expense: $45,264 · Firm income: Not reported

Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers Section 1557, Nondiscrimination in Health Programs and Activities (RIN Number 0945-AA17) Supporting the Reauthorization of the Orphan Drug Program Declaration of National Epilepsy Awareness Month

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office

Mental Health issues (incl. mental health parity, impacts of COVID-19 on TS and co-occurring conditions, suicide prevention,) General Health Care issues (preexisting coverage, medicare/medicaid) Medicare Part D Protected Class Drugs Coverage Research, Medical and Scientific Issues (including BRAIN initiative) Access to Treatment and Care Issues (including step therapy, prior authorization, non-medical switching including S464/HR2163 Safe Step Act) FDA Neuroscience Center of Excellence - BRAIN Act (HR5435) Drug Pricing Broadly CARE for TS Act (S2027/HR3679) Telehealth (need for coverage broad Agency designation) CONNECT for Health Act -S.2742/HR4932, Protection Post-COVID 19 Access to Telehealth Act - HR 366, Telehealth Modernization Act - S.368/HR1332 Collaborative Academic Research Efforts for Tourette Syndrome Act (S.2027/HR3679) Prior Authorization - Ensuring Seniors Timely Access to Care (HR3173) Build Back Better Inflation Reduction Act (HR 5326) Consolidated Appropriation Act (HR2617)

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

General education on triggers of Parkinson's disease, including TCE, paraquat, and other chemicals. Supporting creation of Neuroscience Center of Excellence at FDA. S. 3427, the Neuroscience Center of Excellence Act H.R. 5435, the BRAIN (Bringing Regulatory Advances Into Neuroscience Act of 2021 H.R. 6000, the Cures 2.0 Act S. 3282, the Protect Americas Children from Toxic Pesticides Act (PACTPA) H.R. 3967 / S. 3373 Honoring our Promise to Address Comprehensive Toxics (PACT) Act and other associated legislation

Client expense: $20,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities. H.R. 8585/S. 4851, the National Plan to End Parkinson's Act - to require the U.S. Department of Health and Human Services (HHS) to carry out a project to prevent and cure Parkinson's disease. Among other components of the project, HHS must (1) implement and periodically update a national plan to coordinate and guide efforts to prevent and cure the disease; (2) improve diagnosis, treatment, and care of those with the disease; and (3) address health and other disparities related to the disease. HHS must also conduct annual assessments on the preparation for and response to the increased burden of Parkinson's disease. In addition, the bill establishes a council, comprised of federal and nonfederal stakeholders, to advise HHS on and make recommendations concerning the prevention and cure of Parkinson's disease. Establishing Parkinson's disease ICD-10-CM codes to assist in the continuation and coordination of care and to allow researchers to gather more data to study the progression of Parkinson's among people living with the disease. Expanding access to health care for people living with Parkinson's via telehealth by removing Medicare telehealth geographic and originating site restrictions, extending coverage and reimbursement for health care providers who bill Medicare for providing services via telehealth (including seeing new patients and audio-only telehealth for clinically appropriate services/visits), ensuring payment parity for telehealth and in-person services, and removing Medicare in-person requirements for accessing mental health services via telehealth. H.R. 2617, the Consolidated Appropriations Act, 2023 Establishing separate Medicare payment requirements for diagnostic radiopharmaceuticals, including DaTscans, so health care providers are adequately reimbursed for furnishing diagnostic tests to help validate patients Parkinsons diagnoses. S. 2609/H.R. 4479, Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021 S. 464/H.R. 2163, the Safe Step Act - to amend the Employee Retirement Income Security Act of 1974 (ERISA) to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol to enable people living with Parkinsons disease to access the medications they need to best manage their disease S.4906 Advocating for reauthorization of CDCs National Neurological Conditions Surveillance System (NNCSS) S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT), and Pandemics Act S. 253/H.R.8454, the Cannabidiol and Marihuana Research Expansion Act/ Medical Marijuana and Cannabidiol Research Expansion Act S. 1467/H.R. 2916, the VA Medicinal Cannabis Research Act H.R. 5657, the Medical Marijuana Research Act H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act H.R. 2916/S. 1467, the VA Medical Cannabis Research Act of 2021 H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act S. 1670/H.R. 3321, the Credit for Caring Act H.R. 253, the Adult Day Care Center Enhancement Act H.R. 6000, the Cures 2.0 Act H.R. 4521, the America COMPETES Act of 2022 H.R. 2565/S. 2952, the FDA Modernization Act of 2021 H.R. 5435 BRAIN (Bringing Regulatory Advances Into Neuroscience) Act of 2021 S. 3427, the Neuroscience Center of Excellence Act of 2021 H.R. 6584, the DEPICT (Diverse and Equitable Participation in Clinical Trials) Act S. 331, ABLE (Achieving a Better Life Experience) Age Adjustment Act

H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)

Client expense: $11,123 · Firm income: Not reported

H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)

Client expense: $11,123 · Firm income: Not reported

Mental Health issues (incl. mental health parity, impacts of COVID-19 on TS and co-occurring conditions, suicide prevention) General Health Care issues (preexisting coverage, medicare/medicaid) Medicare Part D Protected Class Drugs Coverage Research, Medical and Scientific Issues (including BRAIN initiative) Access to Treatment and Care Issues (including step therapy, prior authorization, non-medical switching including S464/HR2163 Safe Step Act) FDA Neuroscience Center of Excellence - BRAIN Act (HR5435) Drug Pricing Broadly CARE for TS Act (S2027/HR3679) Telehealth (need for coverage broad Agency designation) CONNECT for Health Act -S.2742/HR4932, Protection Post-COVID 19 Access to Telehealth Act - HR 366, Telehealth Modernization Act - S.368/HR1332 Collaborative Academic Research Efforts for Tourette Syndrome Act (S.2027/HR3679) Prior Authorization - Ensuring Seniors Timely Access to Care (HR3173) Build Back Better Inflation Reduction Act

Client expense: $30,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. S. 4906: National Neurological Conditions Surveillance System Reauthorization Act of 2022 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Inflation Reduction Act of 2022; Subtitle B Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.

Client expense: $250,000 · Firm income: Not reported

Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers Input on federal policies that contribute to racial and ethnic health inequities, as well as potential solutions that could improve health equity Request for Applications for New Members of the Clinical Trials Transformation Initiative/Food and Drug Administration Patient Engagement Collaborative [Docket No. FDA-2017-N-6395]

Client expense: Not reported · Firm income: $24,000

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE

H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)

Client expense: $42,877 · Firm income: Not reported

-H.R. 5376 Inflation Reduction Act, support addressing affordability of health insurance premiums; creating an out-of-pocket cap in Medicare Part D with smoothing mechanism; and barring the use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation. -S. 464/H.R. 2163, Safe Step Act, support passage. -HR 8454 Medical Marijuana and Cannabidiol Research Expansion Act, support passage. -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products. -H.R. 5435, BRAIN Act, S. 3427, Neuroscience Center of Excellence Act and H.R. 6000, Cures 2.0 Act, support creation of a Neuroscience Center of Excellence at the FDA that is patient-focused and related necessary appropriations. -S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 / H.R. 7667 Food and Drug Amendments Act of 2022, ensure that any new regulation of dietary supplements protects access to CBD, support amendment to ban use of certain electric shock devices, support provisions regarding diverse enrollment in clinical trials, support provisions to support orphan drug development

Client expense: $65,000 · Firm income: Not reported

Step Therapy Reform - S. 464 & HR 2163 Safe Step Act FDA Reform - S.3427 - Neuroscience Center of Excellence Act of 2021 FDA Reform - H.R. 6000 - Cures 2.0 Act FDA Reform - H.R.5435 - BRAIN Act of 2021 FDA Reform- H.R.7667 - Food and Drug Amendments of 2022 FDA Reform- S. 4348 FDASLA Act of 2022 Mental Health - H.R.7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 Fiscal Year 2023 Military Construction, Veterans Affairs, and Related Agencies Funding Bill Fiscal Year 2023 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Funding

Client expense: $130,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General education on triggers of Parkinson's disease, including TCE, paraquat, and other chemicals. Supporting creation of Neuroscience Center of Excellence at FDA. S. 3427, the Neuroscience Center of Excellence Act H.R. 5435, the BRAIN Act H.R. 6000, the Cures 2.0 Act S. 3282, the Protect Americas Children from Toxic Pesticides Act H.R. 3967 / S. 3373 Honoring our Promise to Address Comprehensive Toxics (PACT) Act and other associated legislation

Client expense: $31,190 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities Advocating for Parkinson's patients during COVID-19, including extension of health care subsidies Advocating for proposed repeal of Department of Health and Human Services rule entitled Securing Updated and Necessary Statutory Evaluations Timely Advocating on for more specific Parkinson's disease ICD-10-CM codes to assist in the continuation and coordination of care and allow researchers to have data to study the disease progression Advocating for expanding access to care via telehealth S.4906 Advocating for reauthorization of CDCs National Neurological Conditions Surveillance System (NNCSS) S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT), and Pandemics Act S. 253/H.R.8454, the Cannabidiol and Marihuana Research Expansion Act/ Medical Marijuana and Cannabidiol Research Expansion Act S. 1467/H.R. 2916, the VA Medicinal Cannabis Research Act H.R. 5657, the Medical Marijuana Research Act H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act H.R. 2916/S. 1467, the VA Medical Cannabis Research Act of 2021 H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act S. 1670/H.R. 3321, the Credit for Caring Act H.R. 253, the Adult Day Care Center Enhancement Act S. 464/H.R. 2163, the Safe Step Act H.R. 3013, the COVID Vaccine Transportation Access Act H.R. 2503, the Social Determinants Accelerator Act of 2021 H.R. 6000, the Cures 2.0 Act H.R. 4521, the America COMPETES Act of 2022 H.R. 2565/S. 2952, the FDA Modernization Act of 2021 H.R. 5435 BRAIN Act of 2021 S. 3427, the Neuroscience Center of Excellence Act of 2021 H.R. 6584, the DEPICT Act S.Res. 577, A resolution designating April 2022 as "Parkinson's Awareness Month" S. 331, ABLE Age Adjustment Act H.R. 5376, the Inflation Reduction Act of 2022 H.R. 8585/S. 4851, the National Plan to End Parkinson's Act

S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 S.4348: FDASLA Act of 2022; section 506. H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.

Client expense: $450,000 · Firm income: Not reported

Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers Comments on the Affordability of Employer Coverage for Family Members of Employees Submission of telehealth and whole genome sequencing as topics for evidence review NOT-TR-21-027 - Request for Information (RFI): Facilitating the Early Diagnosis and Equitable Delivery of Gene-Targeted Therapies to Individuals with Rare Diseases

Client expense: Not reported · Firm income: $24,000

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE

H.R. 7667- Food and Drug Amendments of 2022, support passage S.4248- Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act, support passage H.R. 5435- BRAIN Act of 2021, establishing a Neuroscience Center of Excellence at the Food and Drug Administration, support passage H.R.315 - Common Sense Cannabis Reform for Veterans, Small Business and Medical Professionals Act, monitor to support H.R. 6000 - Cures 2.0 Act, supporting the goals of Rep. Upton/DeGette's Cures 2.0 initiative aimed at accelerating medical research, patient access to novel therapeutics and authorizing the Administration's Advanced Research Projects Agency for Health (ARPA-H) proposal -support passage S. 3726- CARE for Long COVID Act- support passage S.4447 - Modernizing Accelerated Approval Act, support passage and inclusion in Senate FDASLA package. S. 3799 Prevent Pandemics Act - support passage Lisa Blunt Rochester- Long-COVID RECOVERY NOW Act, support passage (bill number forthcoming)

Client expense: $42,877 · Firm income: Not reported

Mental Health issues (incl. mental health parity, impacts of COVID-19 on TS and co-occurring conditions, suicide prevention) General Health Care issues (preexisting coverage, medicare/medicaid) Medicare Part D Protected Class Drugs Coverage Research, Medical and Scientific Issues (including BRAIN initiative) Access to Treatment and Care Issues (including step therapy, prior authorization, non-medical switching including S464/HR2163 Safe Step Act) FDA Neuroscience Center of Excellence - BRAIN Act (HR5435) Drug Pricing Broadly CARE for TS Act (S2027/HR3679) Telehealth (need for coverage broad Agency designation) CONNECT for Health Act -S.2742/HR4932, Protection Post-COVID 19 Access to Telehealth Act - HR 366, Telehealth Modernization Act - S.368/HR1332 Collaborative Academic Research Efforts for Tourette Syndrome Act (S.2027/HR3679) Prior Authorization - Ensuring Seniors Timely Access to Care (HR3173)

Client expense: $40,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

-Reconciliation legislation, support additional funding for Medicaid home- and community-based services; addressing affordability of health insurance premiums; creating an out-of-pocket cap in Medicare Part D with smoothing mechanism; bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; preserving the Orphan Drug Tax Credit; expand Medicaid. -S. 3799 PREVENT Pandemics Act, incorporate disability into pandemic preparedness legislation Work has stalled on this, we had success in committee but havent done much on it since we could take it out -S. 464/H.R. 2163, Safe Step Act, support passage. -S. 253, Marihuana Research Expansion Act and H.R. 5657, Medical Marijuana Research Act, support passage. -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products. -H.R. 5435, BRAIN Act, S. 3427, Neuroscience Center of Excellence Act and H.R. 6000, Cures 2.0 Act, support creation of a Neuroscience Center of Excellence at the FDA that is patient-focused and related necessary appropriations. - S. 4348 Food and Drug Administration Safety and Landmark Advancements Act of 2022 / H.R. 7667 Food and Drug Amendments Act of 2022, ensure that any new regulation of dietary supplements protects access to CBD, support amendment to ban use of certain electric shock devices, support provisions regarding diverse enrollment in clinical trials, support provisions to support orphan drug development

Client expense: $65,000 · Firm income: Not reported

Step Therapy Reform - S. 464 & HR 2163 Safe Step Act FDA Reform - S.3427 - Neuroscience Center of Excellence Act of 2021 FDA Reform - H.R. 6000 - Cures 2.0 Act FDA Reform - H.R.5435 - BRAIN Act of 2021 FDA Reform- H.R.7667 - Food and Drug Amendments of 2022 FDA Reform- S. 4348 FDASLA Act of 2022 Patient Access - H.R.5801 - HELP Copays Act Mental Health - H.R.7666 - Restoring Hope for Mental Health and Well-Being Act of 2022

Client expense: $160,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

General education on triggers of Parkinson's disease, including TCE, paraquat, and other chemicals. Supporting creation of Neuroscience Center of Excellence at FDA. S. 3427, the Neuroscience Center of Excellence Act H.R. 5435, the BRAIN Act H.R. 6000, the Cures 2.0 Act S. 3282, the Protect Americas Children from Toxic Pesticides Act H.R. 3967 Honoring our Promise to Address Comprehensive Toxics (PACT) Act and other associated legislation

Client expense: $61,153 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

General Parkinson's disease information about symptoms, triggers, health coverage, health costs, social determinants of health related to Parkinson's disease and data collection, research, and health access for underserved communities Advocating for Parkinson's patients during COVID-19, including extension of health care subsidies Advocating for proposed repeal of Department of Health and Human Services rule entitled Securing Updated and Necessary Statutory Evaluations Timely Advocating on for more specific Parkinson's disease ICD-10-CM codes to assist in the continuation and coordination of care and allow researchers to have data to study the disease progression Advocating for expanding access to care via telehealth Advocating for reauthorization of CDCs National Neurological Conditions Surveillance System (NNCSS) S. 3799, the Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT), and Pandemics Act S. 253, the Cannabidiol and Marihuana Research Expansion Act S. 1467/H.R. 2916, the VA Medicinal Cannabis Research Act H.R. 5657, the Medical Marijuana Research Act H.R. 3617, the Marijuana Opportunity Reinvestment and Expungement Act H.R. 2916/S. 1467, the VA Medical Cannabis Research Act of 2021 H.R. 3105, the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act S. 1670/H.R. 3321, the Credit for Caring Act H.R. 253, the Adult Day Care Center Enhancement Act S. 464/H.R. 2163, the Safe Step Act H.R. 3013, the COVID Vaccine Transportation Access Act H.R. 2503, the Social Determinants Accelerator Act of 2021 H.R. 6000, the Cures 2.0 Act H.R. 4521, the America COMPETES Act of 2022 H.R. 2565/S. 2952, the FDA Modernization Act of 2021 H.R. 5435 BRAIN Act of 2021 S. 3427, the Neuroscience Center of Excellence Act of 2021 H.R. 6584, the DEPICT Act S.Res. 577: A resolution designating April 2022 as "Parkinson's Awareness Month" S. 331: ABLE Age Adjustment Act

S. 289/ H.R. 869: Research Investment to Spark the Economy Act of 2021 S. 610/ H.R. 1667: Lorna Breen Health Care Provider Protection Act S. 834/ H.R. 2256: Resident Physician Shortage Reduction Act S. 898: Fair Accountability and Innovative Research Drug Pricing Act of 2021 S. 1024/H.R. 2255: Healthcare Workforce Resilience Act S. 1548/H.R. 3085: Equity in Neuroscience and Alzheimers Clinical Trials (ENACT) Act S. 1810/H.R. 3541: Conrad State 30 and Physician Access Reauthorization Act S. 3427: Neuroscience Center of Excellence Act of 2021 H.R. 2754: COVID-19 Long Haulers Act H.R. 4122: Resident Education Deferred Interest Act of 2021 H.R. 5435: Bringing Regulatory Advances into Neuroscience (BRAIN) Act H.R. 5376: Build Back Better Act; sections 139001-139003, 139101, 139102, 139201, 139202, 31060, 137402, 137405, 30601, 30602, 137301, and 30801 Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Support for creating a Neuroscience Center of Excellence at FDA. Support for eliminating the prohibition on national unique patient identifier. Supporting policies to address the COVID-19 public health emergency, including maintaining telemedicine coverage and ensuring access to affordable health coverage and medications. Support for funding and the reauthorization of the CDC National Neurological Conditions Surveillance System. Medical research funding related to NIH including the BRAIN Initiative, AHRQ, HEAL Initiative, and the Congressionally Directed Medical Research Programs at the Department of Defense. Support for funding for the Pediatric Subspecialty Loan Repayment Program.

Client expense: $120,000 · Firm income: Not reported

Policies related to telehealth Policies related to transition of care for children and youth with special health care needs Request to become Health People 2030 Champion CONNECT for Health Act (S.1512/ H.R. 2903) Cures 2.0 Act (H.R. 6000) BRAIN Act of 2021 (H.R.5435) Policies related to newborn screening Support for caregivers Response to Requests for Information from the Healthy Futures Task Force Response to White House RFI on Strengthening Community Health Through Technology

Client expense: Not reported · Firm income: $24,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Science & Technology Policy (OSTP), SENATE

-Build Back Better Act or similar legislation, support $400 billion for Medicaid home- and community-based services; addressing affordability of health insurance premiums; creating an out-of-pocket cap in Medicare Part D with smoothing mechanism; bar use of discriminatory quality-adjusted life year (QALY) in prescription drug legislation; preserving the Orphan Drug Tax Credit; creating a comprehensive paid family and medical leave program; add vision, dental, and hearing coverage to Medicare; expand Medicaid. -S. 3799 PREVENT Pandemics Act, incorporate disability into pandemic preparedness legislation. -S. 464/H.R. 2163, Safe Step Act, support passage. -S. 253, Marihuana Research Expansion Act and H.R. 5657, Medical Marijuana Research Act, support passage. -Identify and make recommendations on improvements to federal law for access to medical cannabis and medical cannabis products. -H.R. 5435, BRAIN Act, S. 3427, Neuroscience Center of Excellence Act and H.R. 6000, Cures 2.0 Act, support creation of a Neuroscience Center of Excellence at the FDA that is patient-focused and related necessary appropriations.

Client expense: $50,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE